Edit |   |
---|---|
Product Name | Methotrexate (MTX) EIA Reagents |
Description | Bulk OEM Reagents (Reagent 1/ Reagent 2) for automated chemistry analyzers. Methotrexate is a kind of antieoplastic drug used solely or in combination with other antineoplastic drugs for the treatment of leukemia and other diseases. Relatively low doses of methotrexate (approximately 7.5-25 mg/week) have been used in the treatment of nonmalignant diseases such as severe psoriasis, asthma, rheumatoid arthritis sarcoidosis, and transplantation therapy. Intermediate to high doses of methotrexate (approximately 35 mg/m2-12 g/m2) with leucovorin (citrovorum-factor) rescue have been used with favorable results in the treatment of osteogenic sarcoma, leukemia, non-Hodgkin's lymphoma, lung and breast cancer. The efficacy of methotrexate in the treatment of other tumors such as prostatic cancer is being investigated. Methotrexate Assay provides a convenient and efficient method to monitor the drug concentration in serum or plasma. |
Size | 1 liter, 5000 tests |
Concentration | n/a |
Applications | Homogenous Enzyme Immunoassay |
Other Names | MTX |
Gene, Accession, CAS # | n/a |
Catalog # | MTX00SKT |
Price | $3000 |
Order / More Info | Methotrexate (MTX) EIA Reagents from SJK GLOBAL LLC |
Product Specific References | n/a |